Terry Dagnon
2022
In 2022, Terry Dagnon earned a total compensation of $1.4M as Chief Operations Officer at Outlook Therapeutics, a 378% increase compared to previous year.
Compensation breakdown
| Option Awards | $966,730 |
|---|---|
| Salary | $353,077 |
| Other | $114,148 |
| Total | $1,433,955 |
Dagnon received $966.7K in option awards, accounting for 67% of the total pay in 2022.
Dagnon also received $353.1K in salary and $114.1K in other compensation.
Rankings
In 2022, Terry Dagnon's compensation ranked 2,246th out of 5,411 executives tracked by ExecPay. In other words, Dagnon earned more than 58.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,246 out of 5,411 | 59th |
Division Manufacturing | 1,223 out of 2,943 | 58th |
Major group Chemicals And Allied Products | 540 out of 1,314 | 59th |
Industry group Drugs | 495 out of 1,219 | 59th |
Industry Biological Products, Except Diagnostic Substances | 125 out of 284 | 56th |
Source: SEC filing on February 15, 2023.
Dagnon's colleagues
We found two more compensation records of executives who worked with Terry Dagnon at Outlook Therapeutics in 2022.
News
Outlook Therapeutics CEO C Trenary's 2023 pay jumps 32% to $1.8M
February 8, 2024
Outlook Therapeutics Chief Operations Officer Terry Dagnon's 2022 pay jumps 378% to $1.4M
February 15, 2023
Outlook Therapeutics CEO C Trenary receives $7.5M in 2021
January 27, 2022
Outlook Therapeutics CEO Lawrence Kenyon's 2020 pay falls 36% to $1.2M
February 22, 2021